c 1311 has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibby, MC; Burger, AM; Double, JA; Konopa, J | 1 |
| Calabrese, CR; Loadman, PM | 1 |
2 other study(ies) available for c 1311 and Experimental Neoplasms
| Article | Year |
|---|---|
Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.
Topics: Adenocarcinoma; Aminoacridines; Animals; Antineoplastic Agents; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasms, Experimental; Time Factors; Transplantation, Heterologous | 1996 |
Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.
Topics: Aminoacridines; Animals; Antineoplastic Agents; Blood Proteins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Mice; Neoplasms, Experimental; Protein Binding; Reproducibility of Results; Spectrometry, Fluorescence | 1997 |